Bioceres Crop Solutions Corp. · NASDAQ:BIOX

Bioceres Crop Solutions — FY2020 Earnings Presentation

20 slides from Bioceres Crop Solutions's earnings presentation, Sep 10, 2020

  1. Slide 1: Fourth Quarter and Fiscal Year 2020 Earnings Call Presentation

    Slide 1: Fourth Quarter and Fiscal Year 2020 Earnings Call Presentation

    Fourth Quarter and Fiscal Year 2020 Earnings Call Presentation September 10, 2020

  2. Slide 2: Disclaimer And Forward-Looking Statement

    Slide 2: Disclaimer And Forward-Looking Statement

    Disclaimer And Forward-Looking Statement This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, assets, business, debt or other financial instruments of the Company or

  3. Slide 3: Executing on Growth Strategy while Substantially Strengthening Balance Sheet

    Slide 3: Executing on Growth Strategy while Substantially Strengthening Balance Sheet

    Executing on Growth Strategy while Substantially Strengthening Balance Sheet  Continued international expansion supported by leading position in Argentina, plus a more profitable mix - 4Q20 Comparable revenues +46% YoY and +17% to $ 174M in FY20 - 4Q20 Adjusted EBITDA +67% and +13% to $ 46M in FY20

  4. Slide 4: Update on EcoSoy

    Slide 4: Update on EcoSoy

    Update on EcoSoy® Key Highlights Geographical Distribution for FY21  FY20 hectares fully harvested HB4 4519 RG Repositioned  >50% of materials met seed quality and varieties to HB4 5519 performance metrics HB4 hot zones Varieties that met HB4 4619 RG STS expectations and are continued at full scal

  5. Slide 5: Update on EcoWheat

    Slide 5: Update on EcoWheat

    Update on EcoWheat® Key Highlights EcoWheat in the Media  ~7,000 hectares planted out of the 12,000 10 notes that include reserved testimonies of producers, opinion of academics, politicians and decision-  Severe drought conditions prevented some makers of our grower-partners from initiating multi

  6. Slide 6: Successful Completion of Warrant Tender Offer

    Slide 6: Successful Completion of Warrant Tender Offer

    Succesful Completion of Warrant Tender Offer  Company removed all its 24.2M outstanding Warrants for either 0.12 ordinary shares or $0.45 in cash per warrant  Transaction executed in 29 days (from announcement to redemption of non-tendered warrants)  Removed overhang of Bioceres’ outstanding warr

  7. Slide 7: BIOX Warrant Tender Offer Results

    Slide 7: BIOX Warrant Tender Offer Results

    BIOX Warrant Tender Offer Results 24.2M Warrants removed 90% 10% 21.9M 2.3M Warrants validily tendered Warrants redeemed for $0.405 in cash 21.7M 0.2M 2.6M1 $ 0.1M Exchange Shares in Cash in exchange for exchange for Warrants tendered Warrants (.12) tendered ($.45) $ 1.0M 11.7M shares incorporated i

  8. Slide 8: Robust Top Line Growth Driven by Solid Performance Across All Segments

    Slide 8: Robust Top Line Growth Driven by Solid Performance Across All Segments

    Robust Top Line Growth Driven by Solid Performance Across All Segments Comparable Segment Revenues ($ in millions) YoY  Revenues largely linked to US dollar, except in Brazil  4Q20 +46%, driven by strong sales of adjuvants, as well as bio-fungicides, inoculants and seed treatment packs across regi

  9. Slide 9: Crop Protection Highlights

    Slide 9: Crop Protection Highlights

    Crop Protection Highlights Comparable Segment Revenues ($ in millions) YoY  4Q20 +29%, led by sustained expansion in Brazil’s adjuvant market, supported by normalized demand in Argentina. Continued growth in environmentally friendly bio-fungicides  FY20 +13%, on consistent execution of adjuvant gr

  10. Slide 10: Seed & Integrated Products Highlights

    Slide 10: Seed & Integrated Products Highlights

    Seed & Integrated Products Highlights Comparable Segment Revenues ($ in millions) YoY  4Q20 +175%, driven by seed treatment pack sales1 at South African subsidiary and sustained recovery of packs in Argentina, following highly successful pre-season summer crop sales campaign there  FY20 +32%, high

  11. Slide 11: Crop Nutrition Highlights

    Slide 11: Crop Nutrition Highlights

    Crop Nutrition Highlights Comparable Segment Revenues ($ in millions) YoY  4Q20 +46%, strong demand for micro-beaded fertilizer ahead of a winter crops planting season in Argentina, supported by continued penetration of Brazil’s inoculants B2B market  FY20 +18%, on greater demand for micro-beaded

  12. Slide 12: Comparable Consolidated Gross Profit and Margin

    Slide 12: Comparable Consolidated Gross Profit and Margin

    Comparable Consolidated Gross Profit and Margin Gross Profit ($ in millions) & Margin YoY  4Q20 Gross Profit +51%, with margin expanding 138 bps to 48.7%, mainly driven by greater proportion of higher margin S&IP sales within the revenue mix, enhanced by favorable FX and inflation dynamics  FY20 G

  13. Slide 13: Adjusted EBITDA Driven by Top Line Performance and Operating Leverage

    Slide 13: Adjusted EBITDA Driven by Top Line Performance and Operating Leverage

    Adjusted EBITDA Driven by Top Line Performance and Operating Leverage 4Q20 EBITDA Bridge ($ in millions) Adj. EBITDA 17.6% 30.5% Margin 14.7 16 4.5 0.6 14 0.5 12 2.0 10 8.8 0.6 8 1.3 6 4 2 0 Adjusted EBITDA Gross profit Crop Gross profit Seed Gross profit Crop Operating JV's Other income or Adjusted

  14. Slide 14: Strong Balance Sheet: Increased Liquidity and Improved Debt Profile

    Slide 14: Strong Balance Sheet: Increased Liquidity and Improved Debt Profile

    Strong Balance Sheet: Increased Liquidity and Improved Debt Profile  Raised a total of $65 M in FY20 including $15 M in public corporate bonds in 4Q20 due Dec’21  Improved debt maturity profile: long-term debt at 57% of total debt, up from 37% in 4Q19  Enhanced financial liquidity: cash & equival

  15. Slide 15: Higher Cash Generation via Lower Financing Costs

    Slide 15: Higher Cash Generation via Lower Financing Costs

    Higher Cash Generation via Lower Financing Costs  Lowered total net interest expenses and financial commissions by 56% in 4Q20, by reducing average cost of debt and replacing inefficient external working capital sources, resulting in 25% drop in FY20  Strong asset base remains in place to support

  16. Slide 16: Looking ahead

    Slide 16: Looking ahead

    Looking ahead Accelerating HB4® Program  Continue consolidating our HB4 soybean breeding program with our existing licensees and other breeding partners, to expand on Bioceres’ genetics offering  Accelerate international HB4 deployment plans, particularly in the United States and Brazil Strong foc

  17. Slide 17: Exhibits

    Slide 17: Exhibits

    7’ BIOCERES CROP SOLUTIONS EXHIBITS September 10, 2020

  18. Slide 18: Unaudited Consolidated Statement of Comprehensive Income

    Slide 18: Unaudited Consolidated Statement of Comprehensive Income

    Unaudited Consolidated Statement of Comprehensive Income Figures in $ millions Three-month period ended Three-month period ended Fiscal year ended Fiscal year ended 06/30/2020 06/30/2019 06/30/2020 06/30/2019 Total revenue 48.2 49.9 173.1 160.6 Cost of sales (25.3) (28.3) (93.6) (87.0) Gross profit

  19. Slide 19: Unaudited Consolidated Statement of Financial Position

    Slide 19: Unaudited Consolidated Statement of Financial Position

    Unaudited Consolidated Statement of Financial Position Figures in $ millions ASSETS 06/30/2020 06/30/2019 LIABILITIES 06/30/2020 06/30/2019 CURRENT ASSETS CURRENT LIABILITIES Cash and cash equivalents 34.9 3.5 Trade and other payables 57.3 40.6 Other financial assets 21.0 4.7 Borrowings 63.6 66.5 Tr

  20. Slide 20: Contact Us

    Slide 20: Contact Us

    Contact Us Investor Relations Investorrelations@biocerescrops.com (54) 0341 4861100 Investors.biocerescrops.com

Source: Internet Archive copy of s26.q4cdn.com

More decks from Bioceres Crop Solutions Corp.

All 37 Bioceres Crop Solutions decks